MBA Business Administration with Professional Placement
The MBA Business Administration with Professional Placement program at UCLan is designe...
Preston Campus
INTAKE: September
The MSc in Cancer Biology and Therapy program at the University of Central Lancashire is a comprehensive and specialized course focusing on the principles and applications of cancer biology and treatment. Cancer biology is a critical field that plays a pivotal role in understanding the complexities of cancer and developing innovative therapies.
Program Structure: The MSc in Cancer Biology and Therapy program typically spans one year full-time, with part-time options available. It combines theoretical learning with laboratory-based practical experiences.
Core Modules: The program includes essential modules such as Cancer Biology, Molecular Oncology, and Therapeutic Strategies for Cancer. These modules provide a solid foundation in cancer biology principles.
Laboratory Skills: Students gain hands-on experience in advanced laboratory techniques, including cell culture, genetic analysis, and drug screening.
Cancer Genetics: The program explores the genetic factors underlying cancer development and progression, enabling students to understand the molecular basis of the disease.
Immunotherapy: Students learn about cutting-edge immunotherapy approaches and their potential in cancer treatment.
Drug Development: The program covers the process of drug discovery and development, from target identification to clinical trials.
Research Projects: Many programs include research projects where students can work on real-world cancer research challenges, contributing to the advancement of knowledge in the field.
Multidisciplinary Approach: UCLan often encourages a multidisciplinary approach, allowing students to collaborate with experts from various fields, such as oncology and pharmacology.
Ethical Considerations: The ethical aspects of cancer research and therapy are emphasized, ensuring that students understand the importance of ethical conduct in their work.
Industry Engagement: UCLan frequently collaborates with cancer research organizations and pharmaceutical companies, providing students with valuable industry exposure.
Preston Campus
IELTS 6.5
£ 14500
Postgraduate Entry Requirement:
Students must provide:
Work experience: Some postgraduate courses may require relevant work experience in the field.
It is important to note that meeting the minimum entry requirements does not guarantee admission, as the university considers factors such as availability of places and competition for the program. Additionally, some courses may have higher entry requirements or additional selection criteria, such as interviews or portfolio submissions.
Scholarships for International Students at the University of Central Lancashire (UCLan):
It is important to note that the availability, eligibility criteria, and application deadlines for scholarships may vary each year.
Graduates of the MSc in Cancer Biology and Therapy program from the University of Central Lancashire are well-prepared for a variety of career opportunities in the field of cancer research and treatment.
Cancer Research Scientist: Graduates can work as cancer research scientists, conducting experiments and studies to advance our understanding of cancer and develop new therapies.
Oncology Consultant: Many alumni pursue careers as oncology consultants, providing expert guidance on cancer diagnosis and treatment.
Pharmaceutical Researcher: Graduates may work in pharmaceutical companies, focusing on cancer drug development and clinical trials.
Clinical Trials Coordinator: Some students opt for roles as clinical trials coordinators, managing and overseeing cancer clinical trials.
Cancer Educator: Graduates can explore educational roles, teaching and raising awareness about cancer prevention and treatment.
Hospital-based Roles: Alumni may work in hospitals, clinics, or cancer centers, providing patient care and treatment.
Biotechnology Specialist: Graduates with expertise in biotechnology may become specialists in developing innovative cancer therapies.
Further Research: Some alumni choose to pursue further research at the doctoral level, contributing to groundbreaking discoveries in cancer biology and therapy.